Perosphere Pharmaceuticals Inc, A Wholly Owned Subsidiary Of Amag Pharmaceuticals, Inc.
Clinical trials sponsored by Perosphere Pharmaceuticals Inc, A Wholly Owned Subsidiary Of Amag Pharmaceuticals, Inc., explained in plain language.
-
New antidote for blood thinner shows promise in early trial
Disease control CompletedThis study tested an investigational drug called ciraparantag to see if it can quickly reverse the effects of the blood thinner rivaroxaban. Sixty-nine healthy adults aged 50 to 75 took rivaroxaban and then received either ciraparantag or a placebo. The main goal was to measure h…
Phase: PHASE2 • Sponsor: Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
New antidote for blood thinner shows promise in early trial
Disease control CompletedThis study tested a drug called ciraparantag to see if it could quickly reverse the effects of the blood thinner apixaban. Sixty healthy adults aged 50 to 75 took part. The goal was to bring blood clotting time back to normal within an hour and keep it stable for several hours.
Phase: PHASE2 • Sponsor: Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC